Vesalius Longevity Labs today announced the appointment of Dean Henry to its Scientific Advisory Board. Henry is an internationally recognized figure in health optimization, biohacking, and performance, with a network spanning North America, the UAE, and Asia-Pacific.
“Vesalius represents the compliance-forward platform the global longevity medicine community has been waiting for,” said Henry. “The physician-only distribution model, cGMP-aligned sourcing, and public company accountability structure are exactly right for this moment in peptide science.”